Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $17.8000 (2.59%) ($17.3000 - $18.6000) on Fri. Jan. 12, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.04% (three month average) | RSI | 74 | Latest Price | $17.8000(2.59%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 2% a day on average for past five trading days. | Weekly Trend | CAPR advances 5.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) EWG(8%) EWI(8%) PEJ(8%) SKYY(8%) TBT(8%) | Factors Impacting CAPR price | CAPR will decline at least -2.52% in a week (0% probabilities). GLD(-9%) TLT(-8%) GDX(-8%) SLV(-7%) SIL(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.52% (StdDev 5.04%) | Hourly BBV | 0 () | Intraday Trend | 2.9% | | | |
|
5 Day Moving Average | $16.97(4.89%) | 10 Day Moving Average | $16.49(7.94%) | 20 Day Moving Average | $16.05(10.9%) | To recent high | -35.3% | To recent low | 21.9% | Market Cap | $351m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |